Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia.
about
Antibiotic Restriction Might Facilitate the Emergence of Multi-drug Resistance.Implementation of a computerized decision support system to improve the appropriateness of antibiotic therapy using local microbiologic dataImpact of empirical treatment in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. bacteremia. A multicentric cohort study.Impact of empiric antimicrobial therapy on outcomes in patients with Escherichia coli and Klebsiella pneumoniae bacteremia: a cohort study.Diabetes does not affect outcome in patients with Enterobacteriaceae bacteremia.The Use of Bloodstream Infection Mortality to Measure the Impact of Antimicrobial Stewardship Interventions: Assessing the EvidenceEmergence of and risk factors for ciprofloxacin-gentamicin-resistant Escherichia coli urinary tract infections in a region of Quebec.Altered blood glucose concentration is associated with risk of death among patients with community-acquired Gram-negative rod bacteremia.Timing of appropriate empirical antimicrobial administration and outcome of adults with community-onset bacteremiaBacteremia complicating gram-negative urinary tract infections: a population-based study.Major differences exist in frequencies of virulence factors and multidrug resistance between community and nosocomial Escherichia coli bloodstream isolatesRisk factors and prognosis of nosocomial bloodstream infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli.Risk factors and outcomes of infections caused by extremely drug-resistant gram-negative bacilli in patients hospitalized in intensive care units.Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy.Critical analysis of empiric antibiotic utilization: establishing benchmarks.Frequency of occurrence and antimicrobial susceptibility of Gram-negative bacteremia isolates in patients with urinary tract infection: results from United States and European hospitals (2009-2011).Identifying patients harboring extended-spectrum-beta-lactamase-producing Enterobacteriaceae on hospital admission: derivation and validation of a scoring systemCommunity-onset bloodstream infection with multidrug-resistant organisms: a matched case-control studyThe clinical impact of fluoroquinolone resistance in patients with E coli bacteremiaCross-border comparison of the Dutch and German guidelines on multidrug-resistant Gram-negative microorganisms.Antibiotic prophylaxis with intravenous ceftriaxone and fluoroquinolone reduces infectious complications after transrectal ultrasound-guided prostatic biopsyBoth host and pathogen factors predispose to Escherichia coli urinary-source bacteremia in hospitalized patients.The Effect of Inadequate Initial Empiric Antimicrobial Treatment on Mortality in Critically Ill Patients with Bloodstream Infections: A Multi-Centre Retrospective Cohort Study.Incidence of antibiotic-resistant Escherichia coli bacteriuria according to age and location of onset: a population-based study from Olmsted County, Minnesota.Increased multi-drug resistant Escherichia coli from hospitals in Khartoum state, SudanComparison of phenotypic characteristics and antimicrobial resistance patterns of clinical Escherichia coli collected from two unrelated geographical areasUtility of a clinical risk factor scoring model in predicting infection with extended-spectrum β-lactamase-producing enterobacteriaceae on hospital admission.Bacteremic Urinary Tract Infection Caused by Multidrug-Resistant Enterobacteriaceae Are Associated With Severe Sepsis at Admission: Implication for Empirical Therapy.Rapid determination of quinolone resistance in Acinetobacter spp.Revolutionising bacteriology to improve treatment outcomes and antibiotic stewardship.Antimicrobial resistance trends of Escherichia coli bloodstream isolates: a population-based study, 1998-2007.Clinical significance of extended-spectrum beta-lactamases.Regional variations in fluoroquinolone non-susceptibility among Escherichia coli bloodstream infections within the Veterans Healthcare Administration.Reducing inappropriate antibiotic prescribing in the residential care setting: current perspectives.Current management of bloodstream infections.Association between dementia and reduced walking ability and 30-day mortality in patients with extended-spectrum beta-lactamase-producing Escherichia coli bacteremia.Clinical Outcomes and Healthcare Utilization Related to Multidrug-Resistant Gram-Negative Infections in Community Hospitals.Impact on morbidity, mortality and length of stay of hospital acquired infections by resistant microorganisms.Use of antibacterial prophylaxis for patients with neutropenia. Australian Consensus Guidelines 2011 Steering Committee.Changing microbial epidemiology in hematopoietic stem cell transplant recipients: increasing resistance over a 9-year period.
P2860
Q28545750-56DBE17C-4194-44B7-A178-C3519AC695BFQ30848185-E79CE6FA-8EFD-4968-9CD4-AE98EE47DA4AQ31102336-73B0FBB7-E705-4BDC-8FDA-9EA475CDE7A8Q33369556-2B0032FB-023C-4C3F-B78E-65051A9F336FQ33467124-EA8050F3-F09D-4DBF-A2F9-7722421E4A23Q33564316-5611C286-E31D-4C97-914A-B8F6509A468FQ33593668-231CB49B-E714-465F-B54B-D006995C3650Q33612981-BE5D0F48-BDCF-436A-85EF-0999B77FB7E8Q33730706-E1215E8A-239E-42C8-B52F-FB7094E458B9Q33738237-627DCFB1-E23D-4375-A8C2-21FB3E0BA866Q33769703-5BA8898E-5102-4500-BEC2-48CAB1905D6DQ33827095-6651E3C9-1EE3-477D-90D1-81F4BB324362Q33853131-01C39FB2-9403-4723-B469-65AF125E45B1Q34150900-F9A7BD0B-EE3C-4EB3-A0E9-7FEA06199BEEQ34207396-4392E8DA-FCA9-4F12-93EF-E15387F191C2Q35007499-34DD4200-9097-469B-8A92-4086DA014F3BQ35065875-672D04A7-AD28-4536-8320-A5244A178162Q35110090-3B5602DB-142B-4C75-8C4D-8ECC5E27E77FQ35164228-F08304AA-3F21-4694-AA43-1D3C49F75C4BQ35165288-2395284D-B868-4B22-9D26-D6639C2B6576Q35715463-AF318CFA-4632-41A6-8795-A71EA5A93CADQ35977404-30BC0926-D028-4803-B465-22AD345DC459Q36010587-F1495F17-D8B8-4982-8841-194A6D6DAB80Q36513085-B7086933-5803-42BF-95D8-0CD77B734F36Q36569808-5FFF248D-E686-4583-BA45-B0F78F0C9BC1Q36780495-A15A45BE-C0E7-49A1-BE7A-3FC78138339DQ36810340-74822737-0F36-4158-87FB-05C0D5157B73Q36993148-181C22F9-1C78-45FB-9DC2-9E2D3DE71AFCQ37191622-76E507F8-3A6D-43CC-9795-2C11122160DAQ37192145-054972DA-156C-45D6-8C20-B5FB87087AA1Q37217108-0A40F744-B115-4B3F-8651-FC12349FF88BQ37291354-19DF66D7-008B-4D53-81A2-33F2BFCB75C6Q37349628-CF6C553A-81DE-45B6-9F5E-6C4EA798506CQ37490618-42FF474A-3D12-456B-A600-156466F0FCA2Q37768418-283F0C27-D3FC-4596-A1A4-27218EEAA84BQ38628085-EADC88C4-358F-4C8B-A9C7-61829829DCC1Q39304889-8CD7E41A-6965-43B6-9504-BC0C2B5372DFQ40226218-A4963205-A658-4762-92C5-3895D3E82097Q40335974-1F6A4E0C-6251-466F-88BF-488C199A21C1Q41709957-EB0ED7A1-09DE-41DF-A1C4-6A38FCEEA619
P2860
Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Impact of antibiotic resistanc ...... Escherichia coli bacteraemia.
@en
Impact of antibiotic resistanc ...... Escherichia coli bacteraemia.
@nl
type
label
Impact of antibiotic resistanc ...... Escherichia coli bacteraemia.
@en
Impact of antibiotic resistanc ...... Escherichia coli bacteraemia.
@nl
prefLabel
Impact of antibiotic resistanc ...... Escherichia coli bacteraemia.
@en
Impact of antibiotic resistanc ...... Escherichia coli bacteraemia.
@nl
P2093
P356
P1476
Impact of antibiotic resistanc ...... Escherichia coli bacteraemia.
@en
P2093
Galo Peralta
Inés De Benito
J Carlos Garrido
Luis Martínez-Martínez
M Blanca Sánchez
M Eliecer Cano
M Pía Roiz
P304
P356
10.1093/JAC/DKM279
P407
P577
2007-07-20T00:00:00Z